ARKG

ARK$48.63+0.47 (+0.98%)
AUM $2.22BER 0.75%NAV $47.87Holdings 10

Price Chart

Key Statistics

Previous Close

$48.16

Day Range

$47.82$49.15

52-Week Range

$24.82$56.77

Avg Volume

6.1M

Dividend Yield

—

Expense Ratio

0.75%

AUM

$2.22B

Shares Outstanding

34.9M

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare96.64%
Technology2.55%
Cash & Others0.81%

Country Allocation

CountryWeight %
United States90.88%
Switzerland5.60%
United Kingdom2.76%
Other0.75%

Fund Information

Issuer
ARK
Category
Healthcare
Inception Date
Oct 30, 2014
Exchange
BATS
Description
ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors that are relevant to the Fund’s investment theme of the genomics revolution.

Similar ETFs

SymbolNameAUM
XLVState Street Health Care Select Sector SPDR ETF$47.46B
VHTVanguard Health Care ETF$21.80B
VTWOVanguard Russell 2000 ETF$17.30B
XBIState Street SPDR S&P Biotech ETF$10.66B
RWLInvesco S&P 500 Revenue ETF$10.31B

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund issued by ARK that launched on Oct 30, 2014. It currently manages $2.22B in assets under management. The fund charges an expense ratio of 0.75%. The fund holds 10 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 57.9% of the fund

RankSymbolNameWeight %SharesMarket Value
1TXG10X GENOMICS INC-CLASS A8.58%2,485,118$173.3M
2TEMTEMPUS AI INC-CL A7.88%2,495,303$159.2M
3TWSTTWIST BIOSCIENCE CORP7.85%1,171,200$158.7M
4CRSPCRISPR THERAPEUTICS AG5.53%2,233,677$111.7M
5ILMNILLUMINA INC5.01%375,821$101.2M
6ABSIABSCI CORP4.98%10,746,821$100.7M
7NTRANATERA INC4.98%250,837$100.7M
8GHGUARDANT HEALTH INC4.93%611,910$99.7M
9LLYELI LILLY & CO4.29%66,310$86.6M
10CDNACAREDX INC3.89%1,137,747$78.7M
11VCYTVERACYTE INC3.59%1,578,004$72.7M
12BEAMBEAM THERAPEUTICS INC3.49%2,874,405$70.6M
13NRIXNURIX THERAPEUTICS INC2.88%2,283,748$58.3M
14CMPSCOMPASS PATHWAYS PLC2.85%4,958,589$57.7M
15RXRXRECURSION PHARMACEUTICALS-A2.74%15,480,744$55.4M

Detailed Returns

PeriodReturnETF
1D
+0.98%
1W
+2.85%
1M
-8.68%
3M
+29.92%
6M
+63.11%
YTD
+66.96%
1Y
+56.35%
3Y
+117.21%
5Y
-36.42%

Moving Averages

20-Day MA

$50.37

Below 20-Day MA
50-Day MA

$49.31

Below 50-Day MA
200-Day MA

$36.92

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$56.77

Current Price

$48.63

52-Week Low

$24.82

$24.82$56.77

Current Yield

—

Annual Dividend

$2.3445

Frequency

1x/year

Last Ex-Date

Dec 29, 2021

Dividend History

Ex-DateAmountPay Date
Dec 29, 2021$0.3824Dec 31, 2021
Dec 29, 2021$0.3820Dec 31, 2021
Dec 29, 2020$0.7901Dec 31, 2020
Dec 29, 2020$0.7900Dec 31, 2020
Dec 27, 2019$1.0540Dec 31, 2019
Dec 27, 2019$1.0539Dec 31, 2019
Dec 27, 2018$0.4660Dec 31, 2018
Dec 27, 2018$0.2700Dec 31, 2018
Dec 27, 2018$0.1963Dec 31, 2018
Dec 27, 2017$0.3280Dec 29, 2017
Dec 27, 2017$0.1927Dec 29, 2017
Dec 27, 2017$0.1350Dec 29, 2017

Dividend Payments Over Time

Category Comparison

MetricARKGHealthcare(206 ETFs)Innovation(5 ETFs)
Fund Info
Expense Ratio0.75%0.64%0.75%
AUM$2.22B$873.4M$2.98B
Dividend Yield—4.48%0.72%
Avg Volume6.1M251.0K2.2M
Holdings1014216
Performance
1-Month Return-8.70%-1.00%-7.74%
6-Month Return+58.85%+5.56%+12.77%
YTD Return+68.17%+10.43%+14.20%
1-Year Return+53.11%+6.48%+6.89%

Compare with Another ETF

Search for an ETF to compare with ARKG:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.